The positive correlation between BCAP31 expression and drug sensitivity to 5-Fluorouracil, ABT737, Afuresertib, AGI-5198, Alisertib, and AGI-6780 suggests that BCAP31 could serve as a predictive biomarker for the efficacy of these drugs in specific cancers. Here, BCAP31 is linked to cancer.